Form 4: Personalis CEO Christopher Hall Acquires 680,000 Stock Options

Personalis, Inc. CEO Christopher M Hall acquired 680,000 stock options on March 15, 2025, according to a Form 4 filing with the SEC.

Summary

• Christopher M Hall, the President and CEO of Personalis, Inc., acquired 680,000 stock options on March 15, 2025.
• The options have an exercise price of $3.63.
• The options vest in 36 equal monthly installments, starting on April 15, 2025.
• The options expire on March 15, 2035.
• The transaction was reported on a Form 4 filed with the SEC on March 18, 2025.

Sentiment

Score: 6

Explanation: Neutral sentiment. The document simply reports a transaction. The acquisition of stock options by the CEO could be interpreted as a positive sign, but it's a routine part of executive compensation.

Positives

• The CEO's acquisition of stock options could be seen as a positive sign, indicating confidence in the company's future performance.

Industry Context

This is a standard practice for compensating executives in publicly traded companies. Stock options are often used to align the interests of management with those of shareholders.

Comparison to Industry Standards

• Stock option grants are a common form of executive compensation in the biotechnology and personalized medicine industries.
• The size of the grant and the vesting schedule are typical for CEO-level compensation packages.
• Comparing the exercise price to the current market price of Personalis stock would provide further context on the potential value of these options.

Stakeholder Impact

• The stock option grant could potentially incentivize the CEO to improve the company's performance, benefiting shareholders.
• Employees may view the CEO's stock option grant positively, as it aligns the CEO's interests with the company's success.

Key Dates